Sph kinase 1 and Sph kinase 2 assays

EN Eyad Naser
SK Stephanie Kadow
FS Fabian Schumacher
ZM Zainelabdeen H. Mohamed
CK Christian Kappe
GH Gabriele Hessler
BP Barbara Pollmeier
BK Burkhard Kleuser
CA Christoph Arenz
KB Katrin Anne Becker
EG Erich Gulbins
AC Alexander Carpinteiro
ask Ask a question
Favorite

NBD-C18-shingosine (Avanti Polar Lipids) was prepared and dissolved in 5% Triton X-100, and Sph kinase (SphK1) and SphK2 assays were performed in real-time as previously described (33) with slight changes. Briefly, 96-well polypropylene plates were used. Fluorescence emission was measured with a FLUOstar Omega (BMG Labtech). Excitation wavelength was 544 nm, and emission wavelength was 590 nm. Assays were initiated with 20× ATP [20 mM ATP, 200 mM MgCl2, 900 mM Tris-HCl (pH 7.4)] followed by shaking and mixing for 15 s. Assays were prepared as master mixes immediately before use in either SphK1 or SphK2 reaction buffer containing 30 μM of NBD-Sph, 150 nM of rhSphK1 (R&D Systems, 5536-SK-010), or 6.9 nM of rhSphK2 (R&D Systems, 5298-SK-010). ARC39 was added as indicated. SphK1 reaction buffer contained 30 mM of Tris-HCl (pH 7.4), 0.05% Triton X-100, 150 mM of NaCl, 10% glycerol, 1 mM of Na3VO4, 10 mM of NaF, and 10 mM of β-glycero-phosphate. SphK2 reaction buffer contained 30 mM of Tris-HCl (pH 7.4), 0.05% Triton X-100, 200 mM of KCl, and 10% glycerol.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A